RECOVER - Phase 1 COVID-19 group
The population is composed of healthcare workers that have tested positive for COVID-19 and that, upon initial infection, are symptomatic or not.
The population is composed of healthcare workers that have tested positive for COVID-19 and that, upon initial infection, are symptomatic or not.
-
Newborns
-
-
Twins
-
-
Countries
-
-
Territory
-
-
Ethnic Origin
-
-
Health Status
-
-
Other Criteria
-
Exclusion criteria:
- At the time of recruitment are no longer working in a healthcare setting or have been furloughed as a preventive measure;
- Are not fluent in French or English;
- Have no access to a cell phone or internet, as follow-up will be done through text messages and emails.
- Are participating in a clinical trial for preventive treatment of COVID-19 {e.g., high dose Vitamin D (>2000IU/day or ≥10,000IU/wk), colchicine}, who are still on treatment upon recruitment. Can be included if taken for other reasons.
- Have received a COVID-19 vaccine prior to their enrolment in the study.
-
Supplementary Information about selection criteria
-
Of 570 participants, the majority are female (83.0%) and Caucasian (79.3%). The median age is 42. Most worked in acute-care hospitals (54.1%) or public long-term care facilities (24.4%). The most commonly reported profession is nurse/paramedic (40.4%), followed by patient care attendant (12.8%) and physician/medical resident (11.8%).
-
Sources of recruitment
-
-
Specific population
-
Participants from existing studies
-
Specific Population
-
-
Members of an association
-
Supplementary Information
-
Recruitment is done in vaccine study centers (MUHC/CHUSJ Vaccine Center), with additional recruitment in hospitals (CHUM, JGH, MUHC) or CHSLDs, near/where participants work.
Participants are also recruited from the large case-control study conducted by the INSPQ.
-
Participants from Existing Studies
-
- Santé Publique du Québec (INSPQ) (G. De Serres) case-control study
-
Number of Participants
-
570
-
Number of Participants with Biological Samples
-
570